
SFDA hosts their 1st meeting of Arab Authorities Controlling Medicines, promoting Arab integration in the field of medicines control and legislation. Topics discussed included registration procedures, monitoring safety and quality, and the role of medicines control labs. Coordination and alignment with legal and regulatory requirements for medicines are key to facilitating availability and lowering costs for patients.
Recent Posts
New Federal Actions to Combat Misleading Prescription Drug Ads in 2025
Misleading prescription drug ads have become a pressing concern in the United States, prompting decisive federal action. What are the new measures targeting deceptive pharmaceutical advertising, and how will these changes affect public health and healthcare costs? In September 2025, a
Medicare ACO Outcomes: Balancing Surgical Benefits and Costs Under the TEAM Model
Medicare ACO outcomes are a major focus for clinicians, policymakers, and researchers seeking to understand how Accountable Care Organization (ACO) assignment influences patient results and healthcare costs after surgery. Are ACOs improving quality and saving money for Medicare patients undergoin...
UK Risks Underestimating Life Sciences Investment Potential
Life sciences investment UK is at a crucial crossroads. As the government relies on the Green Book framework to guide funding for manufacturing innovation, many experts question whether the true value of advanced life sciences manufacturing is being fully recognized. How does the current appraisa...